+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID04253301

Safety Study of the InnoVein Valve and Delivery System for Treating Chronic Venous Insufficiency

Led by InnoVein · Updated on 2021-09-17

5

Participants Needed

3

Research Sites

256 weeks

Total Duration

AI-Summary

What This Trial Is About

Chronic Venous Insufficiency happens when the valves or walls in the leg veins do not work properly, making it hard for blood to flow back to the heart. This condition causes blood to pool in the legs due to increased pressure and faulty valves. Researchers are studying the InnoVein Valve and Delivery System, a new implant designed to support natural blood flow in affected veins and relieve symptoms by recreating a working valve. The study involves implanting the InnoVein Valve in participants diagnosed with chronic venous insufficiency. This device is biocompatible and intended to improve blood flow by supporting the veins function. The research focuses on evaluating the safety of this valve and delivery system over time. Participants will receive the valve implant and be monitored closely for safety, with a primary focus on the number of major adverse events occurring within 30 days after implantation. The study includes follow-up assessments to track how well the device works and any potential risks. The total duration and detailed procedures are designed to ensure participant safety and gather important safety data.

CONDITIONS

Brief Title

Feasibility of the InnoVein Valve and Delivery System for Chronic Venous Insufficiency

Research Team

I

InnoVen Data Management

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here